Quinapril

Quinapril

SCHEMBL9094436

CCOC(=O)C(CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2CC1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Quinapril. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACE known ✓ P12821 16/20 1.00
ABCB11 O95342 2/20 1.00
PDE3A Q14432 1/20 0.80
LMNA P02545 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinapril SCHEMBL15813 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL13575806 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL29380303 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL29846170 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL678447 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL11286555 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL11294979 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL19361887 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL994608 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL11286551 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0488059-B1 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria HOECHST AG (DE) 1995-09-06 EP claimed
EP-0344572-B1 Composition of angiotensin-converting-enzyme inhibitor with calcium chanell modulators and uses thereof as pharmaceuticals HOECHST AG (DE) 1993-12-08 EP claimed
US-5500434-A MIXTURE OF TRANDOLAPRIL AND FELODIPINE HOECHST AKTIENGESELLSCHAFT (DE) 1996-03-19 US disclosed
US-5401766-A Hypotensive agents with vasodilation HOECHST AKTIENGESELLSCHAFT (DE) 1995-03-28 US disclosed
US-5162362-A Hypotensive agents HOECHST AKTIENGESELLSCHAFT (DE) 1992-11-10 US disclosed
US-5158959-A Treatment of hypertension HOECHST AKTIENGESELLSCHAFT (DE) 1992-10-27 US disclosed
US-5098910-A Hypotensive agents HOECHST AKTIENGESELLSCHAFT (DE) 1992-03-24 US disclosed
US-4975453-A HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; CORONARY THERAPY; LOWER DOSAGE AND SIDE EFFECTS HOECHST AKTIENGESELLSCHAFT (DE) 1990-12-04 US disclosed
EP-0046953-B1 AMINO ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1989-12-06 EP disclosed
EP-0328160-A1 Amino acid derivatives, process to prepare them, composition containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1989-08-16 EP disclosed
EP-0278530-A2 Amino acid derivatives, process for their preparation, agents containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-17 EP disclosed
EP-0065301-A1 Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same MERCK & CO. INC. (US) 1982-11-24 EP disclosed
EP-0046953-A2 Amino acid derivatives, processes for their preparation, compositions containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1982-03-10 EP disclosed